R&D Systems™ Human CCL4/MIP-1 beta Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 271BME050
DescriptionThe Recombinant Human CCL4/MIP-1 beta Protein is derived from E. coli. The Recombinant Human CCL4/MIP-1 beta Protein has been validated for the following applications: Bioactivity.
|Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein.|
|7.8 kDa & 7.3 kDa|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|E. coli-derived human CCL4/MIP-1 beta protein Ala24-Asn92 (major); Pro30-Asn92 (Minor)|
|97%, by SDS-PAGE under reducing conditions and visualized by silver stain.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok